The relationship between platelet–lymphocyte ratio, neutrophil–lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 Fluorourasil Regimen: A single institute experience
| Autor: | Nuriye Ozdemir, Nurullah Zengin, Tulay Eren, Mutlu Dogan, Can L Cigirgan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
Adult
Blood Platelets Male medicine.medical_specialty Survival Neutrophils Lymphocyte neutrophil–lymphocyte ratio Docetaxel Adenocarcinoma Gastroenterology Disease-Free Survival Metastatic gastric cancer Stomach Neoplasms Internal medicine Antineoplastic Combined Chemotherapy Protocols Medicine Humans Lymphocytes lcsh:RC799-869 Aged Retrospective Studies Cisplatin business.industry Liver Neoplasms fungi Retrospective cohort study Middle Aged medicine.disease Prognosis Surgery body regions Regimen platelet–lymphocyte ratio medicine.anatomical_structure Fluorouracil Original Article Female Taxoids lcsh:Diseases of the digestive system. Gastroenterology business medicine.drug |
| Zdroj: | The Saudi Journal of Gastroenterology, Vol 21, Iss 5, Pp 320-324 (2015) Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association |
| ISSN: | 1998-4049 1319-3767 |
| Popis: | Background/Aims: The association between platelet–lymphocyte ratio (PLR), neutrophil–lymphocyte ratio (NLR), and survival with response rates were evaluated in metastatic gastric cancer (MGC). Patients and Methods: MGC patients on firstline modified docetaxel/cisplatinum/5-fluorourasil [mDCF; docetaxel 60 mg/m2 (days 1–5), cisplatin 60 mg/m2 (day 1), 5FU 600 mg/m2 (days 1–5), q3w] were evaluated retrospectively. The cutoff values were 160 for PLR and 2.5 for NLR. Progression-free survival (PFS) and overall survival (OS) were estimated for group I (PLR >160), group II (PLR ≤ 160), group III (NLR ≥ 2.5), group IV (NLR < 2.5), group V (PLR > 160 and NLR ≥ 2.5), group VI (PLR ≤ 160 and NLR 160 and NLR < 2.5) and VIIb (PLR ≤160 and NLR ≥ 2.5)]. Results: One hundred and nine MGC patients were evaluated for basal hematological parameters and survival analysis, retrospectively. Most of the patients were male in their fifties with grade III adenocarcinoma (62.9%) and liver metastasis (46.7%). Patients with PLR > 160 and/or NLR ≥ 2.5 had significantly shorter PFS and OS (P = 0.04, 0.01, 0.019, and P = 0.003, 0.002, 0.000, respectively). Conclusion: High PLR (> 160) and/or NLR (≥ 2.5) seem to be poor prognostic factors in MGC. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|